Rury R Holman Selected Research

Sitagliptin Phosphate (Januvia)

1/2022	Validation of the WATCH-DM and TRS-HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis.
11/2020	Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
1/2020	Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.
1/2020	Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.
12/2019	Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
1/2019	Progression of glucose-lowering diabetes therapy in TECOS.
1/2019	Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.
1/2019	Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.
10/2018	Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
1/2018	Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rury R Holman Research Topics

Disease

96	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2002
40	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
23	Myocardial Infarction 01/2022 - 10/2008
21	Stroke (Strokes) 12/2020 - 04/2010
20	Heart Failure 01/2022 - 12/2006
20	Glucose Intolerance 12/2020 - 10/2006
11	Insulin Resistance 01/2021 - 10/2002
9	Hypoglycemia (Reactive Hypoglycemia) 12/2019 - 02/2002
8	Atrial Fibrillation 10/2021 - 01/2012
7	Hypertension (High Blood Pressure) 01/2022 - 11/2004
7	Unstable Angina 12/2019 - 04/2010
7	Diabetes Mellitus 12/2019 - 07/2006
7	Weight Gain 01/2018 - 02/2002
6	Hyperglycemia 05/2012 - 05/2002
5	Body Weight (Weight, Body) 01/2022 - 02/2002
5	Coronary Disease (Coronary Heart Disease) 12/2020 - 09/2013
5	Renal Insufficiency (Renal Failure) 01/2020 - 06/2013
4	Neoplasms (Cancer) 01/2022 - 11/2017
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 11/2004
4	Vascular Diseases (Vascular Disease) 12/2021 - 01/2016
4	Obesity 01/2020 - 08/2006
4	Blindness (Hysterical Blindness) 01/2020 - 06/2013
4	Pancreatitis 01/2018 - 02/2017
3	Albuminuria 10/2021 - 06/2006
3	Peripheral Arterial Disease 10/2021 - 03/2009
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 06/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 02/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 08/2006
3	Overweight 04/2015 - 11/2006
2	Weight Loss (Weight Reduction) 01/2022 - 04/2015
2	Infections 10/2021 - 01/2020
2	Chronic Renal Insufficiency 01/2021 - 11/2017
2	Acute Coronary Syndrome 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 08/2006
2	Edema (Dropsy) 01/2018 - 12/2006
2	Eye Diseases (Eye Disease) 11/2017 - 07/2006
2	Bone Fractures (Bone Fracture) 11/2017 - 01/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2017
2	Diabetes Complications 06/2013 - 11/2006
1	Rheumatoid Arthritis 01/2022
1	Gangrene 10/2021
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2021
1	Foot Ulcer 10/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Lactic Acidosis 01/2021

Drug/Important Bio-Agent (IBA)

30	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2002
24	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 12/2013
18	Exenatide (Byetta)FDA Link 01/2022 - 04/2016
18	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 10/2002
15	Valsartan (Vals)FDA Link 10/2020 - 10/2008
14	Nateglinide (Starlix)FDA LinkGeneric 10/2020 - 10/2008
12	Insulin (Novolin)FDA Link 10/2021 - 02/2002
9	LipidsIBA 01/2022 - 07/2006
9	LDL CholesterolIBA 10/2021 - 06/2006
9	Pharmaceutical PreparationsIBA 12/2020 - 10/2002
8	HDL CholesterolIBA 01/2022 - 05/2002
8	Rosiglitazone (Avandia)FDA Link 05/2011 - 10/2002
7	CreatinineIBA 01/2022 - 06/2006
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 10/2007
6	omega-Chloroacetophenone (Mace)IBA 12/2021 - 01/2019
6	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2020 - 07/2015
6	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2013
5	Acarbose FDA LinkGeneric 10/2021 - 07/2014
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 01/2018
5	ThiazolidinedionesIBA 10/2020 - 12/2006
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
4	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
4	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2004
4	C-Reactive ProteinIBA 02/2014 - 10/2002
4	AlbuminsIBA 01/2012 - 10/2002
3	SodiumIBA 01/2021 - 10/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2020 - 10/2019
3	Blood Glucose (Blood Sugar)IBA 07/2020 - 02/2014
3	Retinaldehyde (Retinal)IBA 01/2020 - 11/2002
3	GlucosidasesIBA 01/2020 - 07/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 02/2014
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017 - 11/2004
3	CholesterolIBA 01/2012 - 08/2006
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2009 - 12/2006
2	empagliflozinIBA 01/2021 - 01/2020
2	AutoantibodiesIBA 01/2020 - 11/2006
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 01/2017
2	Glycoside Hydrolase InhibitorsIBA 10/2019 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 09/2017 - 10/2012
2	AntigensIBA 08/2006 - 10/2002
2	Fibrinogen (Factor I)FDA Link 08/2006 - 10/2002
1	AnthracyclinesIBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022

Therapy/Procedure

34	Therapeutics 01/2022 - 02/2002
11	Glycemic Control 01/2020 - 02/2002
5	Surgical Amputation (Amputations) 10/2021 - 06/2013
4	Light Coagulation 01/2020 - 11/2002
3	Precision Medicine 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
2	Secondary Prevention 11/2017 - 09/2017
1	Lasers (Laser) 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022